BILL NO. 486

(as introduced)

1st Session, 64th General Assembly
Nova Scotia
3 Charles III, 2024

 

Private Member's Bill

 

Access to PrEP Act

 

Lisa Lachance
Halifax Citadel–Sable Island

First Reading: September 13, 2024

(Explanatory Note)

Second Reading:

Third Reading:

Explanatory Note

This Bill amends the Fair Drug Pricing Act to provide coverage for antiviral drugs for the purpose of pre-exposure prophylaxis from HIV with no copayment.

An Act to Amend Chapter 7
of the Acts of 2011,
the Fair Drug Pricing Act,
to Expand Access to PrEP

Be it enacted by the Governor and Assembly as follows:

1 This Act may be cited as the Access to PrEP Act.

2 Chapter 7 of the Acts of 2011, the Fair Drug Pricing Act, is amended by adding immediately after Section 10 the following Section:

10A (1) Notwithstanding subsection 10(1), antiviral drugs for the purpose of pre-exposure prophylaxis from human immunodeficiency viruses are deemed to be a benefit.

(2) No copayment may be charged in connection with antiviral drugs for the purpose of pre-exposure prophylaxis from human immunodeficiency viruses.

 

---

This page and its contents published by the Office of the Legislative Counsel, Nova Scotia House of Assembly, and © 2024 Crown in right of Nova Scotia. Created September 13, 2024. Send comments to legc.office@novascotia.ca.